Imago BioSciences Current Cash

Imago BioSciences (IMGO) currently reports a current cash of $7.3M as of September 2022. That compares with $85M in the prior-year period — down 91.4% year over year. Use the charts on this page to explore Imago BioSciences's current cash history and peer comparisons.

Imago BioSciences's current cash decreased from $85M to $7.3M — a 91.4% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Imago BioSciences reported $7.3M in current cash as of September 2022. That compares with $85M in the prior-year period — down 91.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $7.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Imago BioSciences, and consider following IMGO for alerts when major investors trade the stock.

Imago BioSciences is classified in the Healthcare sector. On current cash, it currently shows $7.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMGO with unrelated industries.